pSivida Corp. Reports Second Quarter Fiscal Year 2013 Results

[Business Wire] – WATERTOWN, Mass.–(BUSINESSWIRE)– pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial … more

View todays social media effects on PSDV

View the latest stocks trending across Twitter. Click to view dashboard

See who pSivida is hiring next, click here to view